Literature DB >> 11132092

Glycosylation of immunoglobulin light chains associated with amyloidosis.

L A Omtvedt1, D Bailey, D V Renouf, M J Davies, N A Paramonov, S Haavik, G Husby, K Sletten, E F Hounsell.   

Abstract

AL amyloidosis is a fatal disease caused by deposition of immunoglobulin light chains in a fibrillarforin (AL) in various organs. By searching the Kabat database of immunoglobulin sequences using the KabatMan software, we have shown that there is a preponderance of the consensus glycosylation sequon (AsnXxxSer/Thr) in the framework regions of amyloid light chains. We have characterised by computer graphics simulations, NMR spectroscopy and carbohydrate biochemistry the structure and conformation of the oligosaccharide from amyloid protein AL MS (lamba1) and from the amyloid associated Bence Jones protein of patient MH (kappa1). These proteins have glycosylation in the hypervariable complementarity-determining region versus framework region, respectively. Both contained a 2-6 sialylated core fucosylated biantennary chain mostly with bisecting GIcNAc. Together our results suggest that light chain glycosylation may be one of several modifications which may render the protein more prone to amyloid formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11132092     DOI: 10.3109/13506120009146437

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  16 in total

1.  Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains.

Authors:  Lawreen H Connors; Yan Jiang; Marianna Budnik; Roger Théberge; Tatiana Prokaeva; Kip L Bodi; David C Seldin; Catherine E Costello; Martha Skinner
Journal:  Biochemistry       Date:  2007-11-16       Impact factor: 3.162

2.  Nonsecretory multiple myeloma with amyloidosis. A case report and review of the literature.

Authors:  Evariste Gafumbegete; Susann Richter; Ludwig Jonas; Horst Nizze; Josef Makovitzky
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

3.  Proteomics-inspired precision medicine for treating and understanding multiple myeloma.

Authors:  Matthew Ho; Giada Bianchi; Kenneth C Anderson
Journal:  Expert Rev Precis Med Drug Dev       Date:  2020-02-24

4.  An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.

Authors:  Alice Nevone; Maria Girelli; Silvia Mangiacavalli; Bruno Paiva; Paolo Milani; Pasquale Cascino; Maggie Piscitelli; Valentina Speranzini; Claudio Salvatore Cartia; Pietro Benvenuti; Ibai Goicoechea; Francesca Fazio; Marco Basset; Andrea Foli; Martina Nanci; Giulia Mazzini; Serena Caminito; Melania Antonietta Sesta; Simona Casarini; Paola Rognoni; Francesca Lavatelli; Maria Teresa Petrucci; Pier Paolo Olimpieri; Stefano Ricagno; Luca Arcaini; Giampaolo Merlini; Giovanni Palladini; Mario Nuvolone
Journal:  Leukemia       Date:  2022-05-24       Impact factor: 12.883

5.  The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.

Authors:  Gareth J Morgan; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2016-08-26       Impact factor: 5.469

6.  Abnormal N-glycosylation of the immunoglobulin G kappa chain in a multiple myeloma patient with crystalglobulinemia: case report.

Authors:  Ryo Hashimoto; Tosifusa Toda; Hisashi Tsutsumi; Masatsugu Ohta; Mayumi Mori
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

7.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

8.  Phosphorylation as a tool to modulate aggregation propensity and to predict fibril architecture.

Authors:  Nathalie M Valette; Sheena E Radford; Sarah A Harris; Stuart L Warriner
Journal:  Chembiochem       Date:  2011-12-15       Impact factor: 3.164

Review 9.  Localized AL amyloidosis: a suicidal neoplasm?

Authors:  Per Westermark
Journal:  Ups J Med Sci       Date:  2012-02-15       Impact factor: 2.384

10.  A strategy for synthesis of pathogenic human immunoglobulin free light chains in E. coli.

Authors:  Paola Rognoni; Francesca Lavatelli; Simona Casarini; Giovanni Palladini; Laura Verga; Paolo Pedrazzoli; Giovanna Valentini; Giampaolo Merlini; Vittorio Perfetti
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.